Viewing nowBeyaril Tablets 2mg (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 200705107 · Approved 2007.05.03 · Insurance code 694000540
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as a treatment to improve blood sugar control in patients with type 2 diabetes. Patients should take this medication alongside dietary and exercise therapy to aid in blood sugar management. It can be used alone, but if blood sugar control is inadequate, it may be combined with insulin or other hypoglycemic agents. Especially when sufficient effect is not achieved with sulfonylureas or metformin, combining this medication can enhance efficacy. This medication helps improve blood sugar control and assists in diabetes management.
The dose should be adjusted individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses greater than 4 mg provide little additional benefit, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered when weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. With combination therapy using this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a state of coma. Additionally, it should not be administered to patients who have had allergic reactions to this medication or sulfonylureas, or those with severe liver or kidney dysfunction. It is also safer for women who are pregnant or may become pregnant, as well as those who are breastfeeding, not to take this medication. Insulin therapy is recommended for patients with severe infections, pre- and post-surgery, or severe trauma, so this medication should not be used in those cases. Patients with gastrointestinal disturbances such as diarrhea or vomiting may be at risk as it can affect drug absorption. This medication contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. During the initial dosing period, there is a high risk of hypoglycemia; therefore, careful monitoring of blood sugar levels is essential. Patients at higher risk for hypoglycemia include the elderly, those with poor nutritional status or who skip meals, and those with irregular eating habits. Excessive exercise, dietary changes, and alcohol consumption can also increase the risk of hypoglycemia. Patients with impaired kidney or liver function, as well as those with other endocrine disorders, may also be sensitive to hypoglycemia. If other medications that interact with this drug are being taken, care should also be taken in managing blood sugar levels. Hypoglycemic symptoms may occur while taking this medication, including headache, severe hunger, nausea, fatigue, confusion, drowsiness, decreased consciousness, etc. Severe hypoglycemia may lead to seizures or coma, requiring immediate treatment. Additionally, temporary visual disturbances may occur due to changes in blood sugar levels. Gastrointestinal symptoms may include nausea, vomiting, abdominal pain, and diarrhea, with rare reports of abnormal liver function or blood abnormalities. Allergic reactions such as itching, rash, and hives may occur, and in severe cases, they can progress to respiratory distress or shock. During treatment with this medication, regular meals, exercise, and weight management are crucial, as is continuous monitoring of blood sugar control. If hypoglycemia occurs, consuming sugar-containing foods can alleviate symptoms. It is important to inform other hospitals or pharmacies about the use of this medication and diabetes status. In stressful situations such as surgery or infection, blood sugar control may become difficult, necessitating a switch to insulin therapy. This medication is excreted via the kidneys, so dosage adjustments may be necessary for the elderly or patients with reduced kidney function. In cases of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment, which may include inducing vomiting, gastric lavage, or glucose injection. This medication is not recommended for children due to lack of established safety and efficacy. Pregnant or breastfeeding women should not use this medication as it can harm the fetus or newborn, and insulin therapy should be initiated if needed. This medication can interact with various other drugs, so if other medications are being taken, it is necessary to consult a doctor or pharmacist. Particular care should be taken with blood sugar changes when used in conjunction with beta-blockers, antibiotics, or steroids. Finally, this medication should be stored out of reach of children and should be kept in its original container sealed properly for safety.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairments, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, biliary secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, anemia, agranulocytosis, pancytopenia, itching, hives, rash, difficulty breathing, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitive reactions of the skin, reduced serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius (room temperature).
Green rectangular tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.